Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Matlashewski G et al. (1984) EMBO J. 3: 3257–3262.
Wolf D, Laver-Rudich Z and Rotter V (1985) Mol. Cell. Biol. 5: 1887–1893.
Harlow E et al. (1985) Mol. Cell. Biol. 5: 1601–1610.
Matlashewski GJ et al. (1987) Mol. Cell. Biol. 7: 961–963.
Buchman VL et al. (1988) Gene 70: 245–252.
Ara S et al. (1990) Nucleic Acids Res. 18: 4961.
Beckman G et al. (1994) Hum. Hered. 44: 266–270.
Thomas M et al. (1999) Mol. Cell. Biol. 19: 1092–1100.
Storey A et al. (1998) Nature 393: 229–234.
Bonafe M et al. (2002) Biochem. Biophys. Res. Commun. 299: 539–541.
Dumont P et al. (2003) Nat. Genet. 33: 357–365.
Marchenko ND, Zaika A and Moll UM (2000) J. Biol. Chem. 275: 16202–16212.
Boyd SD, Tsai KY and Jacks T (2000) Nat. Cell Biol. 2: 563–568.
Geyer RK, Yu ZK and Maki CG (2000) Nat. Cell Biol. 2: 569–573.
Leu JI et al. (2004) Nat. Cell Biol. 6: 443–450.
Hsu YT and Youle RJ (1997) J. Biol. Chem. 272: 13829–13834.
Chipuk JE et al. (2004) Science 303: 1010–1014.
Mihara M et al. (2004) Mol. Cell. 11: 577–590.
Sjalander A et al. (1996) Carcinogenesis 17: 1313–1316.
Wu X et al (2002) J. Natl. Cancer Inst. 94: 681–690.
Granja F et al. (2004) Cancer Lett. 210: 151–157.
Weston A et al. (1994) Carcinogenesis 15: 583–587.
Birgander R et al. (1995) Carcinogenesis 16: 2233–2236.
Rosenthal A et al. (1998) Lancet 352: 871–872.
Jones JS et al. (2004) Clin. Cancer Res. 10: 5845–5849.
Shen H et al. (2002) Cancer Lett. 183: 123–130.
Sullivan A et al. (2004) Oncogene 23: 3328–3337.
Felley-Bosco E et al. (1993) Am. J. Hum. Genet. 53: 752–759.
Li X et al. (2005) J. Biol. Chem. 280: 24245–24251.
Bond GL et al. (2004) Cell 119: 591–602.
Arva NC et al. (2005) J. Biol. Chem. 280: 26776–26787.
Oliner JD et al. (1993) Nature 362: 857–860.
Bougeard G et al. (2005) J. Med. Genet. [E-pub ahead of print].
Hong Y et al. (2005) Cancer Res. 65: 9582–9587.
Swinney RM et al. (2005) Leukemia 19: 1996–1998.
Zhang X et al. (2005) Hum. Mutat. [E-pub ahead of print].
Alhopuro P et al. (2005) J. Med. Genet. 42: 694–698.
Campbell IG, Eccles DM and Choong DY (2005) Cancer Lett. [E-pub ahead of print].
Hu Z et al. (2006) Int. J. Cancer 118: 1275–1278.
Ma H et al. (2005) Cancer Lett. [E-pub ahead of print].
Inga A et al. (2002) Mol. Cell. Biol. 22: 8612–8625.
el-Deiry WS et al. (1992) Nat. Genet. 1: 45–49.
Tomso DJ et al. (2005) Proc. Natl. Acad. Sci. USA 102: 6431–6436.
van Heemst D et al. (2005) Exp. Gerontol. 40: 11–15.
Tyner SD et al. (2002) Nature 415: 45–53.
McGregor JM et al. (2002) J. Invest. Dermatol. 119: 84–90.
Su L et al. (2003) Lung Cancer 40: 259–266.
Bahl R et al. (2000) Oncogene 19: 323–328.
Ralhan R et al. (2000) Clin. Cancer Res. 6: 2440–2447.
Contente A et al. (2002) Nat. Genet. 30: 315–320.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murphy, M. Polymorphic variants in the p53 pathway. Cell Death Differ 13, 916–920 (2006). https://doi.org/10.1038/sj.cdd.4401907
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.cdd.4401907
This article is cited by
-
Linkage disequilibrium and haplotypes of five TP53 polymorphisms in oesophageal cancer patients
Journal of Genetics (2020)
-
Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population
Tumor Biology (2014)
-
The Association Between TP53 Arg72Pro Polymorphism and Lung Cancer Susceptibility: Evidence from 30,038 Subjects
Lung (2013)
-
Colorectal cancer: a researcher’s perspective of the molecular angel’s gone eccentric in the Vale of Kashmir
Tumor Biology (2013)
-
p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case–control study
Molecular Biology Reports (2012)